Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children
Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children: Superiority Randomized Clinical Trial
Sponsor: Brasilia University Hospital
Listed as NCT03171740, this PHASE3 trial focuses on Emergence Delirium and remains completed. Sponsored by Brasilia University Hospital, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Aug 2018 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brasilia University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .